INSIGHTS ON DRUG DEVELOPMENT
-
Simplifying Antibody-Drug Conjugate Payload Synthesis
ADC's offer precise, targeted therapy by delivering cytotoxic agents directly to diseased cells. Learn how this method minimizes harm to healthy tissue and revolutionizes treatment for cancer.
-
CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic
As CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.
-
Scientific Data Is Not AI‑Ready By Default
Convert siloed laboratory data into trusted, AI-ready assets. Learn to enforce data integrity principles at the point of origin to streamline analytics and reduce GxP compliance risks.
-
Tablet Edge Erosion – Solutions For Friability
Addressing tablet edge erosion and friability involves adjusting formulation, tablet design, tooling, press setup, and operation speed to improve tablet robustness and reduce weight loss.
-
Accelerating mRNA Therapy Production With Digital Innovation10/21/2025
Scaling mRNA therapies requires more than innovation—it demands precision. Discover how digital tools like automation and analytics are helping life science companies streamline production.
-
Formulation Development Of Enterically Protected Spray Dried Dispersions11/17/2025
Adrulipase spray-dried dispersions were evaluated to create an orally delivered, enteric-protected enzyme. The lead formulation provided the best acid protection, rapid release, and stability.
-
Transforming Research Through Lab Automation7/6/2026
Self-driving labs bring automation and AI together to transform research. Learn about how continuous experimentation and real-time learning unlock faster insights and more efficient paths to innovation.
-
Getting Breakthrough Biotechnologies To Market8/4/2026
Biotechnology moves quickly, and successful innovation depends on more than breakthrough science. Learn how adaptable strategies can help teams connect emerging tools and manage uncertainty.
-
How Solid-State Characterization Shapes Drug Development7/23/2026
Mark Benger, Site Director at Cambrex Edinburgh, on solid-state characterization as an insurance policy — front-loaded work that quietly determines whether a program survives the jump from kilos to tonnes.
DRUG DEVELOPMENT SOLUTIONS
-
The commercialization of a combination product can be a complex process that involves obtaining the proper data, choosing a drug delivery system, developing a regulatory strategy and conducting clinical trials—all of which can increase development risks and affect your molecule’s time to market.
-
Patch-clamp amplifiers from, whole-cell, and two electrode recordings, single channels to large macroscopic recordings
The Axon Instruments® series of amplifiers provide best-in-class solutions for the entire range of patch-clamp experiments.
-
Dissection Perfection
Laser Microdissection (LMD, also known as Laser Capture Microdissection or LCM) enables users to isolate specific single cells or entire areas of tissue. Powered by a unique laser design and dynamic software, Leica LMD systems allow users to easily isolate Regions of Interest (ROI) from entire areas of tissue down to single cells or even subcellular structures such as chromosomes.
-
AST’s line of table-top machines, GENiSYS® Lab, are ideal systems for drug product development and cGMP production applications. Each system is designed to automate the critical aseptic operations for vial, syringe and cartridge processing to reduce contamination risk and product variability. These table-top systems are engineered to have complete compatibility with cleanroom environments, including Laminar Air Flow Hoods, Bio-Safety Cabinets and aseptic isolators.
-
Whether you require a particular expertise or a complete, experienced integrated small molecule discovery team, Curia can provide a high-performance solution to help turn your vision into reality.